Hemodynamic Monitoring Market Size to Reach Valuation of USD 1,566.7 Million in 2028

14 Sep 2022
www.biospace.com
Hemodynamic monitoring is the process of measuring various blood flow parameters. The main devices used for this purpose are arterial line and central venous catheter. Arterial lines are inserted into the radial or femoral artery to measure the pressure, while central venous catheters are inserted into the internal jugular or subclavian veins to measure the central venous pressure. In addition to these, other devices used for hemodynamic monitoring include Swan-Ganz catheter, pulmonary artery catheter, and Doppler flow probe. The global hemodynamic monitoring market size is expected to reach USD 1,566.7 Million at a steady CAGR of 6.1% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cardiovascular diseases and technological advancements are expected to create significant growth opportunities for the market during the forecast period. The market is anticipated to be driven by the rising number of geriatric population and growing awareness about early detection & management of chronic diseases. According to a report published by the United Nations in 2017, the global population aged 60 years or above is projected to reach nearly 2 billion by 2050 from 900 million in 2015. Furthermore, the World Health Organization (WHO) has estimated that the number of people suffering from cardiovascular diseases will rise to 23.6 million by 2030. Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ Technological advancements in hemodynamic monitoring devices are expected to create significant growth opportunities for the market during the forecast period. For instance, in March 2018, Philips launched IntelliVue X3 mobile cardiac output monitor with the aim of providing clinicians with a real-time view of a patient's hemodynamic status. This device is integrated with Philips' advanced iFR Simplicity software that provides an easy-to-use interface for calculating Fractional Flow Reserve (FFR). Some Key Highlights from the Report Key players in the market include GE Healthcare, Drager Medical GmbH, Edward Lifesciences Corporation, Philips Medical, Hemo Sapiens, Inc., Deltex Medical, Lidco Group, Schwarzer Cardiotek GmbH, Tensys Medical Inc., and Koninklijke Philips NV. These players are focused on launching new products and expanding their geographic reach to gain a competitive edge in the market. For instance, in August 2018, Getinge AB launched a new version of ARYX hemodynamic monitoring system that includes an advanced software for improved patient care. In terms of product type, the arterial line products segment is expected to hold the largest market share in 2028. This growth can be attributed to the fact that arterial lines offer a direct and accurate measure of central hemodynamics as compared to other indirect measures. Also, arterial lines are more commonly used in critical care settings as they provide real-time data on MAP, cardiac output, and SVR. In terms of application, the intensive care units (ICU) segment is expected to hold the largest market share in 2028. This growth can be attributed to the fact that hemodynamic monitoring is extensively used in ICU settings to guide fluid therapy and inotropes/vasopressors. Also, hemodynamic monitoring is helpful in early detection of organ dysfunction and predicting clinical outcomes in critically ill patients. On the basis of end-use, the hospitals & clinics segment is expected to generate the largest revenue in 2028. Increasing number of surgeries and growing adoption of hemodynamic monitoring devices are anticipated to drive the demand for these devices in hospitals. North America is expected to hold the largest market share in 2028 owing to the presence of major players in the region and rising awareness about early detection & management of chronic diseases. For instance, in October 2018, Edwards Lifesciences Corporation launched the fourth-generation HemoSphere monitoring system that provides clinicians with a real-time view of global hemodynamics. This system is integrated with an iFR Simplicity software that offers an easy-to-use interface for calculating Fractional Flow Reserve (FFR). Browse Full Report Description + Research Methodology + Table of Content + Infographics@ Emergen Research has segmented the global hemodynamic monitoring devices market on the basis of product, type, end-use, and region: Product Outlook (Revenue, USD Million; 2018–2028) Monitors Disposables Type Outlook (Revenue, USD Million; 2018–2028) Minimally Invasive Hemodynamic Monitoring Systems Invasive Hemodynamic Monitoring Systems Noninvasive Hemodynamic Monitoring Systems End-use Outlook (Revenue, USD Million; 2018–2028) Hospitals Clinics and ambulatory care centers Home care settings Regional Outlook (Revenue, USD Million; 2018–2028) North America U.S. Canada Mexico Europe Germany U.K. France Spain BENELUX Rest of Europe Asia Pacific China India Japan South Korea Rest of APAC Latin America Brazil Rest of LATAM Middle East & Africa Saudi Arabia UAE Israel Rest Of MEA Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ Explore More Reports Emergen Research: Smart Building Market Photolithography equipment market Animal Ultrasound Market Aviation Fuel Systems Market Optically Clear Adhesive Market Small Caliber Ammunition Market Metaverse market Smart irrigation market Ceramic fiber market Acrylic resin market About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Contact Us: Eric Lee Corporate Sales Specialist 14671 110 Avenue, Surrey, British Columbia, V3R2A9 Emergen Research | Web: Direct Line: +1 (604) 757-9756 E-mail: sales@emergenresearch.com Emergen Research Media Citations: Visit for More Insights: Explore Our Custom Intelligence services | Growth Consulting Services Press Release Available @ Latest Published Titles Smart Cities Market | Smart Learning Market Trending Titles Humanoid Robot Market | Incident Response Market
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.